# Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia

> **NCT01189279** · PHASE1 · COMPLETED · sponsor: **Allergan** · enrollment: 42 (actual)

## Conditions studied

- Alopecia
- Alopecia, Androgenetic
- Baldness

## Interventions

- **DRUG:** bimatoprost Formulation A
- **DRUG:** bimatoprost Formulation B
- **DRUG:** bimatoprost Formulation C

## Key facts

- **NCT ID:** NCT01189279
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-01
- **Final completion:** 2011-02
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2013-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01189279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01189279, "Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT01189279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*